H Trademark

Trademark Overview


On Wednesday, April 22, 2015, a trademark application was filed for H with the United States Patent and Trademark Office. The USPTO has given the H trademark a serial number of 86605519. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 8, 2023. This trademark is owned by Hisun Pfizer Pharmaceuticals Co., Ltd.. The H trademark is filed in the Pharmaceutical Products category with the following description:

Vitamin preparations; medicines for human purposes for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, and adrenocortical insufficiency; capsules for pharmaceutical purposes for the treatment of hypertension, hyperlipidemia, schizophrenia, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystiti; pharmaceutical preparations for the treatment of Cancers, the preven...
h

General Information


Serial Number86605519
Word MarkH
Filing DateWednesday, April 22, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 8, 2023
Registration Number5148801
Registration DateTuesday, February 28, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 25, 2016

Trademark Statements


Description of MarkThe mark consists of a stylized letter "H".
Goods and ServicesVitamin preparations; medicines for human purposes for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, and adrenocortical insufficiency; capsules for pharmaceutical purposes for the treatment of hypertension, hyperlipidemia, schizophrenia, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystiti; pharmaceutical preparations for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, community-acquired pneumonia, urogenital tract infection, endocarditis, bacterial infection, meningitis, and granulocytopenia; chemico-pharmaceutical preparations for the treatment of cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Hematologic Disorders, humanases , Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, Lower respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis, bacteremia, community-acquired pneumonia, gynecological infections, urogenital tract infection, endocarditis, bacterial infection, ,meningitis, and granulocytopenia; analgesics; drugs for medical purposes for the treatment of cancers, the prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, Bacterial septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, bacteremia, community-acquired pneumonia, septicemia, urogenital tract infection, endocarditis, bacterial infection, urinary tract infection, meningitis, granulocytopenia, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency; capsules for medicines sold empty; sedatives; tranquillizers; biological preparations for medical purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; chemical preparations for pharmaceutical purposes for the treatment of cancers, prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Community-acquired pneumonia, Nosocomial pneumonia, intra-abdominal infections , Skin and skin structure infections, endocarditis, pneumonia, urinary tract infection, Gynecological infections, meningitis, septicemia, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis; chemical preparations for medical purposes for the treatment of cancers, the prevention of organ rejection in renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergies, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Community-acquired pneumonia, Nosocomial pneumonia, Pseudomonas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, Streptococcus anginosus, Streptococcus intermadius, Streptococcus constellatus, bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, clostridium perfringens, Peptostreptococcus micros, urogenital tract infection, endocarditis, pneumonia, urinary tract infection, Gynecological infections meningitis, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis; antibiotics; Injectable pharmaceuticals for the treatment of Cancers, the prevention of organ rejection by renal transplant patients, hypertension, hyperlipidemia, hypercholesterolemia, heart disease, prevention of chest pain, chronic congestive heart failure, diabetes, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, depression, obsessive-compulsive disorder, schizophrenia, epilepsy, seizures, spasms, Endocrine Disorders, adrenocortical insufficiency, respiratory tract infections, Urinary tract infections, Intra-abdominal infections, Skin and skin structure infections, septicemia, Gynecological infections, Febrile neutropenic infections, Bone and joint infections, Polymicrobic infections, Urethritis, non-gonococcal urethritis, prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, Superficial pyogenic infection, Deep suppurative disease, bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, Suppurative lung disease, Syphilis, Otitis media, nasosinusitis, hypognathadenitis, Dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, Peritonitis and Septicemia, community-acquired pneumonia, urogenital tract infection, endocarditis, bacterial infection, meningitis, and granulocytopenia; Bulk drugs, namely active pharmaceutical ingredients for a wide variety of pharmaceuticals; biochemical medicines for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; blood products, namely, blood and blood plasma; tinctures, namely, pharmaceutical preparations deriving from crude drugs being immersed in alcohol; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; radium for medical purposes; radioactive substances for use in nuclear medicine; isotopes for medical purposes; radioactive substances for medical purposes; oxygen baths preparations for medical use; gases for medical use; oxygen for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants for hygienic purposes; disinfectants; contact lens solution; contact lens cleaning preparations; cleaning solutions for use with contact lenses; bacteriological culture mediums; bouillons for bacteriological cultures; nutritive substances for microorganisms for medical purposes; cultures of microorganisms for medical and veterinary use; dietetic pasta, crackers and sugar for medical use; nutritional supplements; food for babies; infant milk powder; air purifying preparations; disinfectants for chemical toilets; medicines for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections , Skin and skin structure infections, meningitis, septicemia; biological preparations for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections, Skin and skin structure infections, meningitis, septicemia; chemical preparations for veterinary purposes for the treatment of Pneumonia, urinary tract infection, Gynecological infections , Skin and skin structure infections, meningitis, septicemia; dietary supplements for animals; pesticides; vermin destroying preparations; disinfectant wipes; wadding for medical purposes; dental abrasives; dental mastics
Pseudo MarkHISUN
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHANHUI PHARMACEUTICALS CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressHANGZHOU CITY, ZHEJIANG PROVINCE
CN

Party NameHisun Pfizer Pharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressZhejiang Province
CN

Party NameHisun Pfizer Pharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressZhejiang Province
CN

Party NameHisun Pfizer Pharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressZhejiang Province
CN

Trademark Events


Event DateEvent Description
Friday, September 8, 2023CANCELLED SEC. 8 (6-YR)
Monday, February 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 27, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 19, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 28, 2017REGISTERED-PRINCIPAL REGISTER
Friday, January 20, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, December 21, 2016NOTICE OF ALLOWANCE CANCELLED
Friday, January 20, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 21, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 24, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 24, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 24, 2016FINAL REFUSAL E-MAILED
Wednesday, February 24, 2016FINAL REFUSAL WRITTEN
Saturday, January 30, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 29, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 29, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 3, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 3, 2015NON-FINAL ACTION E-MAILED
Monday, August 3, 2015NON-FINAL ACTION WRITTEN
Saturday, August 1, 2015ASSIGNED TO EXAMINER
Saturday, May 2, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 25, 2015NEW APPLICATION ENTERED